Please assess the completion status of the following clinical trial:

Trial Title: Perioperative Fosfomycin in the Prophylaxis of Urinary Tract Infection in Kidney Transplant Recipients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients transplanted in the Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran.~Exclusion Criteria:~* Allergy to Fosfomycin disodium or Trimethoprim / Sulfamethoxazole

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Fosfomycin disodium (Type: EXPERIMENTAL): * Fosfomycin disodium 4 g intravenously: 3 hours before kidney transplant surgery, 3 hours before urinary catheter removal and 3 hours prior to ureteral catheter removal.~* Trimethoprim / Sulfamethoxazole (160/800 mg) 1 tablet orally every 24 hours.
- Trimethoprim / Sulfamethoxazole (Type: ACTIVE_COMPARATOR): * Trimethoprim / Sulfamethoxazole (160/800 mg) 1 tablet orally every 24 hours.~* Intravenous placebo solution at the same time of application of fosfomycin disodium in the experimental arm.

Based on this trial design, predict the completion outcome and termination type (if applicable).